Estandarización de un procedimiento espectrofotométrico para la cuantificación de polisacárido capsular de Neisseria meningitidis serogrupo X / Standardization of a spectrophotometric procedure for the quantification of Neisseria meningitidis serogroup X capsular polysaccharide

En el presente trabajo se realiza la estandarización del procedimiento espectrofotométrico de determinación de polisacárido capsular e intermedios de Neisseria meningitidis serogrupo X, mediante la determinación de los grupos fosfodiéster presentes en su estructura, por el método de Chen. Se realizó un análisis de los siguientes criterios para la estandarización: linealidad, precisión (repetibilidad y precisión intermedia) y exactitud. Se demostró mediante el diseño experimental y los procedimientos estadísticos empleados que el método es lineal (r > 0,99), el coeficiente de variación del factor respuesta < 5 por ciento, la desviación estándar relativa de la pendiente < 2 por ciento, no existiendo diferencia estadísticamente significativa entre el intercepto de la ecuación con respecto a cero; exacto, porque no existe diferencia estadísticamente significativa entre la concentración determinada en un material de trabajo y su concentración nominal; también demostró ser repetible, pues el coeficiente de variación de las concentraciones de la muestra evaluada (2,44; 2,43; 0,88 por ciento para las concentraciones bajas, medias y altas, respectivamente) es inferior al 3 por ciento y no existen diferencias estadísticamente significativas entre las medias de los resultados obtenidos por dos analistas, evaluados durante cuatro días a tres niveles de concentración. La precisión intermedia es satisfactoria(AU)

The present work comprises the standardization a spectrophotometric procedure for assessing Neisseria meningitidis, serogroup X capsular polysaccharide and their intermediates of modification, the phosphodiesters groups present in its structure, based on Chen method. An analysis of the following standardization criteria was performed: linearity, precision (repeatability and intermediate precision) and accuracy. It was demonstrated through the experimental design and the statistical procedures used that the method is linear (r > 0.99), the coefficient of variation of the response factor < 5 percent, the relative standard deviation of the slope < 2 percent, with no statistically significant difference between the intercept of the equation with respect to zero; exact, because there is no statistically significant difference between the concentration determined in a work material and its nominal concentration; it also proved to be repeatable, because the coefficient of variation of the concentrations of the sample (2.44; 2.43; 0.88 percent for low, medium and high concentrations respectively) is less than 3 percent and there is no statistically significant difference between the means of the results obtained by two analysts, evaluated for four days at three concentration levels. Its intermediate precision was satisfactory(AU)

Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007-2019)

Abstract The aim of this study was to compare the trajectory of serogroups causing Invasive Meningococcal Disease (IMD) in the Santa Catarina (SC) state with those of whole Brazil. A retrospective analysis of all IMD cases reported from January 2007 to December 2019 was carried out. During the study period, 26,058 IMD cases were registered in Brazil and 644 and in SC state alone. Overall, Brazil showed progressive reduction in cases since 2010, when the meningococcal C conjugate vaccine was introducted on National Immunization Program, while SC showed an increase in total cases since 2013, particularly from serogroups W and C. Serogroups distribution was significantly different between Brazil and SC. The emergence of serogroup W highlights the improved meningococcal surveillance through increased accuracy in identification methods in SC state. This finding is important for discussing recommendations of quadrivalent (ACWY) conjugate vaccines in different geographical areas of Brazil.

Neisseria meningitidis aislada de muestras de hombres que tienen sexo con hombres / Neisseria meningitidis isolated from patients in men who have sex with men

Resumen En los períodos 2000-2004 y 2014-2015 se investigó la presencia de Neisseria meningitidis en 1.143 y 544 hombres que tienen sexo con hombres respectivamente, atendidos en el marco de un programa de enfermedades de transmisión sexual. Se determinó la prevalencia de este agente, su distribución en serogrupos y su sensibilidad a los antimicrobianos. Se obtuvieron hisopados faríngeos, rectales y uretrales, que se sembraron en medio selectivo Thayer Martin modificado. La identificación se realizó mediante pruebas bioquímicas convencionales y por espectrometría de masas (MALDI-TOF). En el segundo período estudiado, sobre 85 aislamientos procedentes de faringes se investigaron los serogrupos B, C, W e Y mediante PCR. Se determinó la CIM de penicilina, ceftriaxona, rifampicina, azitromicina y ciprofloxacina en 66 aislamientos obtenidos en el primer período y en 102 logrados en el segundo. La prevalencia de N. meningitidis fue del 17,8% en el primer período y del 28,1% en el segundo; este microorganismo se aisló más frecuentemente de fauces. Los serogrupos hallados fueron B (31,5%), Y (7,6%) y W (3,3%), con un 9,8% de aislamientos no capsulados; los restantes corresponderían a otros serogrupos. El 34,8% y el 63,7% de los aislados estudiados correspondientes al primer y segundo período, respectivamente, tuvieron sensibilidad intermedia a la penicilina, y un 11,8% de los evaluados en el segundo período fueron resistentes a dicho antibiótico. Todos los aislados estudiados fueron sensibles a ceftriaxona y a ciprofloxacina (excepto 3, con CIM entre 0,25 y 0,5(g/ml), el 3% fueron resistentes a rifampicina y el 2% fueron no sensibles a azitromicina. La portación de N. meningitidis en hombres que tienen sexo con hombres fue elevada y hubo un alto porcentaje de cepas no sensibles a penicilina. El serogrupo B fue prevalente.

Abstract During the periods 2000-2004 and 2014-2015, Neisseria meningitidis was investigated in men who have sex with men, 1143 and 544 respectively, who consulted in the sexually-transmitted disease program. Prevalence, serogroup distribution and susceptibility to antibiotics were determined. Pharyngeal, rectal and urethral swabs were cultivated on selective Thayer-Martin modified medium. The identification was performed by biochemical tests and mass spectrometry by MALDI-TOF. Serogroups B, C, W and Y were investigated by PCR in 85 isolates recovered from the pharynx belonging to the second period. MICs of penicillin, ceftriaxone, rifampicin, azithromycin and ciprofloxacin were determined for 66 and 102 isolates from periods 1 and 2 respectively, according to CLSI. The prevalence of N. meningitidis was 17.8% and 28.1%, in periods 1 and 2 respectively; the isolates were mainly recovered from the pharynx. The distribution of serogroups was B 31.5%; Y 7.6%; W 3.3% and 9.8% non-capsulated and the rest would belong to other serogroups. Isolates classified as intermediate to penicillin were 34.8% and 63.7% (first and second periods, respectively); moreover, 11.8% of the isolates from the second period were resistant. All isolates were susceptible to ceftriaxone, to ciprofloxacin (except 3 isolates with MIC values between 0.25 and 0.5(g/ml), 3% were resistant to rifampicin and 2% were not susceptible to azithromicin. The prevalence of N. meningitidis carriage in men who have sex with men was high with a high rate of penicillin non-susceptible isolates. B was the prevalent serogroup.

A propósito de la epidemia meningocóccica chilena (1941-1942): el niño con shock séptico hace 80 años desde la perspectiva médica y social / About the Chilean meningococcal epidemic (1941-1942): the children with septic shock 80 years ago from a medical and social perspective

Resumen: En nuestro país, la enfermedad meningocóccica presenta una baja endemia y alta letalidad, con exis tencia de brotes epidémicos, algunos de ellos de carácter histórico, como el acaecido durante la pri mera mitad del siglo pasado. La acción de un grupo de médicos, pioneros en los aspectos clínicos, de investigación y docencia, junto al personal de salud que constituía su equipo, inmersos en una política pública sanitaria exitosa, permitieron consolidar el cuidado necesario del niño enfermo de esta grave patología, como también de muchas otras, posibilitando así el desarrollo de una propuesta estructurada y científica a la luz del conocimiento disponible en aquella época. Por ello, luego de 80 años, es importante revisar los diversos aspectos clínicos, fisiopatológicos y terapéuticos, además del contexto hospitalario y social de esta exitosa historia del sistema de salud público chileno.

Abstract: In our country, meningococcal disease has a low endemic and high lethality, with epidemic out breaks; some of them of historical character, like the one happened during the first half of the last century. The action of a group of doctors, pioneers in clinical, research and teaching aspects, together with the health personnel that constituted their team, immersed in a successful public health policy, allowed to consolidate the necessary care of the sick child of this serious pathology, as well as many others, thus enabling the development of a structured and scientific proposal, in the light of the knowledge available at that time. Therefore, after 80 years, it is important to review the various clini cal, pathophysiological and therapeutic aspects, in addition to the hospital and social context, of this successful history of the Chilean public health system.

Vacuna cubana antimeningocócica VA-MENGOC-BC®: Treinta años de uso y potencialidades vigentes / Cuban Meningococcal Vaccine VA-MENGOC-BC®: 30 Years of Use and Future Potential

La enfermedad meningocócica provoca cada año más de 500.000 casos y 85.000 muertes en el mundo y un 20 por ciento de los sobrevivientes sufre secuelas. En Cuba, en 1980, la incidencia llegó a 14,4 por 100.000 habitantes para todas las edades y fue declarada como el principal problema de salud del país. En niños menores de 1 año se reportaron más de 120 casos por 100.000 habitantes en algunas provincias. En 1989, investigadores en La Habana, Cuba desarrollaron una vacuna contra meningococo B y C; VA-MENGOC-BC®, la primera en el mundo eficaz contra el meningococo del serogrupo B. Su eficacia de 83 por ciento se demostró en un estudio de campo prospectivo a doble ciegas, aleatorizado, contra placebo. En su producción se empleó por primera vez la tecnología vesicular o proteoliposómica. Esta vacuna se usó en una campaña de vacunación masiva y posteriormente fue incluida en el Programa Ampliado de Inmunización en Cuba y tuvo un impacto acumulado sobre la incidencia de la enfermedad meningocócica del serogrupo B superior a 95 por ciento (93 por ciento-98 por ciento). La vacunación masiva y sistemática cambió el espectro de cepas del meningococo en los portadores asintomáticos sanos y la circulación de cepas en las poblaciones hacia fenotipos no virulentos. La enfermedad dejó de ser un problema de salud en el país. VA-MENGOC-BC® es la vacuna contra la enfermedad meningocócica del serogrupo B que se aplicó en el mayor número de susceptibles en el mundo. En América Latina se administraron más de 60 millones de dosis. En varios países donde se ha usado VA-MENGOC-BC®, circulan cepas diferentes a la vacunal y contra todas ellas se demostró un elevado porcentaje de efectividad (55%-98 por ciento en menores de 4 años y 73 por ciento-100 por ciento en mayores de 4 años). VA-MENGOC-BC® y su tecnología proteoliposómica han tenido impacto y mantienen su potencialidad, no solo en la enfermedad meningocócica, sino en el desarrollo de otras vacunas y adyuvantes(AU)

Every year, meningococcal infection by Neisseria meningitidis causes over 500,000 cases and 85,000 deaths in the world, with 20 percent of survivors suffering sequelae. In Cuba its incidence in 1980 reached 5.9 cases per 100,000 population; about 80 percent of cases were serogroup B, prompting health authorities to declare meningococcal disease the country's main public health problem. Several provinces reported over 120 cases per 100,000 children aged <1 year, overwhelmingly serogroup B. At that time, no vaccines existed with proven efficacy against N. meningitidis serogroup B, nor was there a vaccine candidate that could be successful in the short term. By 1989, researchers in Havana had developed a Cuban meningococcal B and C vaccine, VA-MENGOC-BC®, the world's first against serogroup B meningococcal disease. Its efficacy of 83 percent was demonstrated in a prospective, randomized, double-blind, placebo-controlled field study. Vaccine production used vesicle or proteoliposome technology for the first time. The same year, the World Intellectual Property Organization awarded its gold medal to the main authors of the VA-MENGOC-BC® patent. The vaccine was used in a mass vaccination campaign and later included in Cuba's National Immunization Program, with a cumulative impact on incidence of serogroup B meningococcal disease greater than 95 percent (93 percent-98 percent). Mass, systematic vaccination shifted the spectrum of meningococcal strains in healthy asymptomatic carriers and strains circulating among population groups toward nonvirulent phenotypes. The disease ceased to be a public health problem in the country. VA-MENGOC-BC® is the most widely applied vaccine against serogroup B meningococcal disease in the world. Over 60 million doses have been administered in Latin America. In several countries where it has been applied, in which strains other than the vaccine-targeted strains circulate, VA-MENGOC-BC® has demonstrated effectiveness against all (55 percent-98 percent in children aged ≥4 years and 73 percent-100 percent in children aged >4 years). The vaccine and its proteoliposome technology have had an impact and continue to have potential, not only for meningococcal disease, but also for development of other vaccines and adjuvants(AU)

Plan de acción nacional frente a la emergencia de la cepa W-135 responsable de enfermedad meningocócica invasora en Chile, 2012-2013 / National action plan for the emergence of invasive meningococcal disease in Chile, 2012-2013

Invasive meningococcal disease is challenging for public health, mainly when it manifests with sudden changes in incidence, serogroups and hypervirulent clones that spread in the population, causing great alarm due to its sequelae and often fatal course, a situation that occurred in Chile, starting at week 26 of the year 2012. To face this scenario, an organization of multidisciplinary teams was required, called W-135 Action Plan in Chile, which included sanitary alerts, education, reinforcement of the epidemiological surveillance of suspicious cases, immediate diagnosis through state-of-the-art techniques, blocking of contacts, communication plans, and, from the 42nd week, ON the vaccination campaign was started for children aged from 9-months-old to less than 5 years of age. The vaccination strategy had a great impact on the decrease in incidence (1.3 to 0.1/100,000) and case fatality rate in the vaccinated population (23% to 0%), with a high safety profile, leading to its subsequent inclusion in the national immunization program. The ability to develop molecular, clinical and epidemiological studies allowed us to better understand the situation, supporting public health policy decisions for its control. The W-135 Action Plan implemented by the Ministry of Health in Chile, to manage the outbreak of meningococcal disease by Neisseria meningitidis serogroup W, demonstrated that the coordination of these efforts, through an organized Action Plan, allows the implementation of campaigns at the national level achieving high coverage of risk populations in short periods of time, generating a positive impact on the health of the population.

Prevalência e fatores associados ao estado de portador de Neisseria spp. em núcleos familiares: estudo de base populacional / Prevalence and factors associated with Neisseria spp. carrier state in family households population-based study

Introdução - O estado de portador assintomático ocorre quando o hospedeiro alberga o agente etiológico sem apresentar doença. Os fatores associados ao estado de portador de Neisseria não patogênica (NNP) e Neisseria meningitidis (Nm) diferem entre si, no entanto, as características epidemiológicas de ambas ainda são pouco exploradas. Objetivos - Estimar a prevalência, analisar possíveis diferenças em distintos estratos sociais, identificar o genótipo das cepas isoladas, assim como, investigar fatores associados ao estado de portador de Nm e de NNP em núcleos familiares residentes em Cuiabá-MT. Método - Estudo transversal de base populacional, desenvolvido de 07/2016 a 07/2017, incluindo todos os moradores de uma amostra probabilística estratificada composta de 243 núcleos familiares (domicílios) de área urbana, em bairros de alta e baixa renda do município de Cuiabá. Foram incluídos os domicílios com ao menos uma criança de 12 e 60 meses de idade. Todos os residentes nos domicílios selecionados foram submetidos a coleta de swab de orofaringe para o isolamento de Neisseria spp. Para a comparação de proporções utilizou-se o teste do qui-quadrado. Foram estimadas as razões de prevalências (RP) com seus respectivos intervalos de confiança 95% (IC95%) e para a investigação de fatores associados ao estado de portador de Nm e de NNP foram utilizados modelos de regressão de Poisson. O ajuste das variáveis no modelo final foi avaliado pelo teste de Hosmer e Lemeshow. Resultados: Foram estudados 1.050 indivíduos residentes em 233 núcleos familiares. A prevalência de portadores de Neisseria spp. foi de 10,6% (111/1.050), a de Nm de 2,4% (25/1.050) e de NNP de 8,2% (86/1.050). Dentre 111 portadores, 62 (56,0%) foram por N. lactamica, 25 (22,0%) por Nm, 21 (19,0%) por N. subflava., duas (2,0%) por N. mucosa e uma (1,0%) por N. polysaccharea. Das Nm, 76% (19/25) eram não grupáveis, 16% (4/25) eram do sorogrupo B, 4% (1/25) do sorogrupo C e 4% (1/25) do sorogrupo W. A prevalência de Nm em bairros de baixa renda foi de 2,8% (23/816) e nos de alta renda de 0,8% (2/234) (p=0,058), com uma razão de prevalência (RP) de 3,3 (IC95%:0,8-13,9). A prevalência de NNP em bairros de baixa renda foi de 8,2% (67/816) e em bairros de alta renda de 8,1% (19/234), com uma RP de 1,0 (IC95%:0,6-1,6). Permaneceram independentemente associados ao estado de portador de Nm após ajuste para conviver com tabagista no domicílio e por número de pessoas por dormitório: i) residir em bairro de baixa renda (RPajustada=2,6); ii) faixa etária de 5 a 14 anos (RPajustada=2,7); iii) faixa etária de 15 a 29 anos (RPajustada=2,4) e faixa etária de 30 e anos e mais (RPajustada=1,4). Após o ajuste para a infecção respiratória nos últimos cinco dias, apresentar asma, três ou mais pessoas por dormitório e sexo masculino, mostraram-se independentemente associados ao estado de portador de NNP: i) pertencer a faixa etária de cinco a 14 anos de idade (RPajustada=2,8) e de menores de cinco anos de idade (RPajustada=7,2); ii) residir em casa precária/quitinete (RPajustada=2,1). Conclusões - O contexto social influencia o estado de portador de Nm e NNP. As vacinas conjugadas meningocócicas podem prevenir doenças direta e indiretamente e tais resultados podem subsidiar a elaboração de estratégias de intervenção, especialmente para a identificação de grupos alvo de programas de vacinação

Introduction - The asymptomatic carrier state occurs when the host harbors the etiologic agent without presenting disease. The associated factors with the carrier state of non-pathogenic Neisseria (NNP) and Neisseria meningitidis (Nm) differ among them, however, the epidemiological characteristics of both are still poorly explored. Objectives - To estimate the prevalence, to analyze possible differences in different social strata, to identify the genotype of the isolated strains, as well as to investigate associated factors with the Nm and NNP carrier state in family\'s households living in Cuiabá-MT. Methods - A cross-sectional study was conducted in 07/2016 a 07/2017, in the city of Cuiabá, including all residents of a stratified probabilistic sample which was composed by 243 urban households (families nucleus) with high and low income neighborhoods of the city of Cuiabá. Households with at least one child between 12 and 60 months age were included. All residents in the selected households were submitted to oropharynx swab collection for the isolation of Neisseria spp. To compare proportions the chi-square test was used. For the estimates of prevalence ratios (PR) and the respective 95% confidence intervals (95% CIs), for the analysis of the associated factors with Nm and NNP carrier state Poisson regression models were used. The adjustment of the variables in the final model was evaluated by the Hosmer e Lemeshow test. Results - A total of 1,050 individuals residing in 233 families nucleus were studied. The prevalence of Neisseria spp. was of 10.6% (111/1,050), Nm of 2.4% (25/1,050) and NNP of 8.2% (86/1,050). Among 111 carriers, 62 (56.0%) were by N. lactamica, 25 (22.0%) by Nm, 21 (19.0%) by N. subflava, two (2.0%) by N. mucosa and one (1.0%) by N. polysaccharea. Of the Nm, 76% (19/25) were non-grouping, 16% (4/25) were serogroup B, 4% (1/25) serogroup C and 4% (1/25) serogroup W. Prevalence of Nm in low-income neighborhoods was 2.8% (23/816) and high-income (0.8%) (2/234) (p=0.058), with a prevalence ratio of 3.3 (95% CI:0.8-13.9). The prevalence of NNP in low-income neighborhoods was 8.2% (67/816) and in high-income neighborhoods of 8.1% (19/234), with a PR of 1.0 (95% CI:0,6-1,6). They remained independently associated with Nm state after adjusting to live with a smoker at home and by number of people per dormitory: i) living in a low-income neighborhood (PRadjusted=2.6); ii) age group of 5 to 14 years (PRadjusted=2.7); iii) age range of 15 to 29 years (PRadjusted=2.4) and age group of 30 years and over (PRadjusted=1.4). After adjusting for respiratory infection in the last five days, presenting asthma, three or more people per dormitory and male sex, were independently associated with NNP status: i) belonging to the age group of five to 14 years of age (PRadjusted=2.8) and of children under five years of age (RPadjusted=7.2); ii) residing in a precarious home/kitchenette (PRadjusted= 2.1). Conclusions - The social context influences the carrier state of Nm and NNP. Meningococcal conjugate vaccines can prevent diseases directly and indirectly and such results may support the development of intervention strategies, especially for the identification of target groups of vaccination programs

A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1-24 years in the city of Embu das Artes, São Paulo, Brazil

ABSTRACT Meningococcal carriage is a prerequisite for invasive infection. This cross-sectional study assessed the pharyngeal carriage prevalence in healthy subjects aged 1-24 years in Embu das Artes city, São Paulo, Brazil. Pharyngeal swabs were examined for the presence of Neisseria meningitidis. The isolates were tested for different serogroups using agglutination and polymerase chain reaction. A logistic regression model assessed any independent association between Neisseria meningitidis carriage and various risk factors. A total of 87/967 subjects (9%, 95% Confidence Interval (CI): 7.3-11.0) tested positive for N. meningitidis: 6.2% (95% CI: 3.8-9.4) in 1-4 years, 8.5% (95% CI: 5.1-13.0) in 5-9 years, 12.5% (95% CI: 7.8-18.6) in 10-14 years, 12.6% (95% CI: 7.4-19.7) in 15-19 years and 9% (95% CI: 4.9-14.9) in 20-24 years age groups. Highest carriage prevalence was observed in adolescents 10-19 years old. Serogroup C was predominant (18.4%) followed by serogroup B (12.6%). The 15-19 years age group showed a significant association between number of household members and carriers of N. meningitidis. This cross-sectional study is the first in Brazil to evaluate meningococcal carriage prevalence and associated factors in a wide age range.

Situación epidemiológica de las meningoencefalitis bacterianas / Epidemiological situation of bacterial meningoencephalitis

Se describen los casos de meningoencefalitis bacterianas exponiendo el análisis histórico de algunas variables y a continuación la información desde la Semana epidemiológica (SE) 1 a la 25 del año 2017 que provienen de la notificación por canales oficiales: SNVS (módulos C2/SIVILA) y SIC (Sistema de Información epidemiológica de CABA). El análisis de las infecciones invasivas no meníngeas será realizado en próximas actualizaciones. Los casos fueron notificados a través de estos sistemas por los efectores públicos y privados de la Ciudad. El análisis de los mismos se realizó de manera individual a fin de evitar duplicaciones, excluyendo los casos descartados e integrando la información en una base unificada. Se incluyeron como residentes de CABA a todos aquellos que se domicilian en la Ciudad y aquellos casos atendidos en efectores de la CABA cuyo domicilio es desconocido al momento del análisis. La construcción de las tasas, se realizó en base a las proyecciones poblacionales aportadas por la Dirección de Estadística y Censos (DGEyC) de la Ciudad Autónoma de Buenos Aires. (AU)

Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013

BACKGROUND Meningococcal C conjugate (MenC) vaccine was introduced as part of the Brazilian National Immunisation Program in 2010 for children < 1 year of age. OBJECTIVES The study objective was to evaluate the impact of this vaccination strategy. METHODS An observational, mixed ecological and analytical study was conducted, based on time series panel data from surveillance records (2001-2013). FINDINGS A total of 37,538 of meningococcal disease cases were recorded during the study period. Of these, 19,997 were attributed to serogroup C. A decrease in meningococcal disease serogroup C (MDC) incidence among children aged < 1 year [65.2%; 95% confidence interval (CI): 20.5-84.7%] and 1-4 years (46.9%; 95%CI: 14.6-79.1%) were found in the three years following vaccination introduction. Vaccination impact on the reduction of MDC incidence varied from 83.7% (95%CI: 51.1-100.0%) in the Midwest region to 56.7% (95%CI: 37.4-76.0%) in the Northeast region. MAIN CONCLUSIONS Vaccination against MDC in Brazil had a positive impact on the population of children aged < 1 year, across all regions, and on the 1-4 year-old cohort. Nevertheless, in our view there is scope for improving the vaccination strategy adopted in Brazil.

Epidemiología de la enfermedad por meningococo en Colombia / Epidemiology of meningococcal disease in Colombia

Objetivo: Describir la situación epidemiológica de la enfermedad meningocócica en Colombia. Material y métodos: Estudio descriptivo que recopiló información de diferentes fuentes pertenecientes al Sistema Nacional de Vigilancia en Salud Pública. Las variables fueron analizadas de forma descriptiva y se calcularon las tasas de incidencia cuando los datos requeridos estuvieron disponibles. Resultados: Durante el periodo 2005-2011 se notificaron 1.065 casos, lo que representó un promedio anual de incidencia de 0,36/100.000 habitantes. De estos, se confirmaron tan solo el 46%, lo que apunta a la existencia de una importante brecha de notificación y confirmación. La mayor incidencia se encontró en menores de un año (5,4-6,9/100.000 habitantes) y el 50% de los casos se presentaron en menores de 10 años. Discusión: La Neisseria meningitidis serogrupo B representó la mayor proporción de los aislamientos; sin embargo, en los últimos años los serogrupos Y y C han tenido un repunte importante. Los síntomas fueron en general inespecíficos, el curso de la enfermedad fue rápido y la letalidad fue alta (13,3%). Conclusiones: Existe la necesidad de mejorar las herramientas disponibles para la vigilancia. Las acciones preventivas deben estar dirigidas a lactantes y niños, con protección contra los serogrupos Y y C. Es necesaria la investigación de estrategias contra el serogrupo B.

Objectives: The purpose of this paper was to describe the epidemiology of meningococcal disease in Colombia. Materials and methods: This was a descriptive study based on data from various sources in the National Surveillance System. The variables were analysed descriptively and the incidence rates were estimated when the required data were available. Results: During the 2005-2011 period, 1,065 cases were reported, which represented an annual mean incidence of 0.36/100.000 inhabitants. Of these, only 46% were confirmed, which reveals a gap between reporting and confirmation. The greatest incidence was observed in infants younger than one year (5.4-6.9/100,000) and 50% of the cases occurred in children under 10 years of age. Discussion: Neisseria meningitidis serogroup B represented the greatest proportion of isolates; however, serogroups Y and C have been increasing recently. The symptoms were non-specific, the course of the disease was rapid and the lethality high (13.3%). Conclusions: There is a need to improve the available tools for diagnosis and surveillance. Prevention must be oriented toward infants, toddlers and children including protection against serogroups C and Y. Research into strategies for prevention against serogroup B is also necessary.

Impacto da implantação da vacina conjugada na incidência de meningite meningocócica do tipo C em crianças menores de cinco anos no Sul de Santa Catarina / Impact of the conjugated vaccine implementation on the incidence of meningococcal meningitis type C in children under five in southern Santa Catarina

Introdução: A Doença Meningocócica (DM) é uma infecção bacteriana aguda causada pela Neisseria meningitidis. Acomete principalmente crianças menores de cinco anos, sobretudo as menores de um ano. Suas manifestações clínicas variam desde doença leve até síndrome séptica e/ou meningite. Diante da letalidade da doença, o Ministério da Saúde incluiu no calendário vacinal, no segundo semestre de 2010, a vacina adsorvida meningocócica C (conjugada). Justificativa: Considerando a recente implementação da vacina no serviço público, é necessário avaliar o impacto desta na saúde da população. Este estudo tem como objetivo descrever a ocorrência de Meningite Meningocócica do tipo C em crianças menores de cinco anos na macrorregional Sul do Estado de Santa Catarina dois anos antes (2008 e 2009) e dois anos depois (2011-2012) após a campanha vacinal contra o meningococo C, realizada no ano de 2010. Métodos: Este é um estudo observacional do tipo transversal. Resultados/Discussão: No período estudado, houve apenas cinco casos confirmados de doença meningocócica. O baixo número de casos deve-se provavelmente à ampla utilização da vacina em clínicas particulares já em anos anteriores aos estudados. Nenhuma criança morreu devido à meningite meningocócica ou meningococcemia, sendo que estudos no Brasil em períodos anteriores à vacinação mostraram letalidade em torno de 20%. Conclusão: O menor número de casos e menor mortalidade pela DM demonstram maior efetividade da Vigilância Epidemiológica e efetividade do diagnóstico precoce (AU)

Introduction: Meningococcal disease (MD) is an acute bacterial infection caused by Neisseria meningitidis. It mainly affects children under five years of age, especially children under one year. Its clinical manifestations range from mild disease to septic syndrome and/or meningitis. Given the lethality of the disease, the Ministry of Health included the adsorbed meningococcal C vaccine (conjugated) in the vaccine calendar in the second half of 2010. Justification: Considering the recent implementation of the vaccine in the public service, it is necessary to evaluate its impact on the health of the population. This study aims to describe the occurrence of Meningococcal Meningitis type C in children under five years of age in the southern macro-region of the State of Santa Catarina two years before (2008-2009) and two years after (2011-2012) the vaccination campaign against meningococcus C carried out in 2010. Methods: This is an observational cross-sectional study. Results/Discussion: In the study period, there were only five confirmed cases of meningococcal disease. The low number of cases is likely due to the wide use of the vaccine in private clinics already years before those studied here. No child died due to meningococcal meningitis, and studies in Brazil prior to vaccination show lethality around 20%. Conclusion: The lower number of cases and lower mortality due to MD demonstrate greater effectiveness of the Epidemiological Surveillance and the effectiveness of early diagnosis (AU)

Enfermedad meningocóccica en la Región Metropolitana de Chile y su correlación con factores ambientales / Meningococcal disease in the Metropolitan Region of Chile and its correlation with environmental factors

Introduction: Meningococcal disease (MD) is a public health problem worldwide, due to its high morbidity and mortality. Most cases occur in sub-Saharan Africa, where there is a marked seasonal pattern with predominance during the dry season. Objectives: To describe the morbidity of MD in the Metropolitan Region (MR) of Chile and explore whether there is a correlation between the number of cases with the levels of atmospheric particulate matter PM 10 and PM 2.5, relative humidity (RH), temperature and total environmental pollen. Materials and Methods: Ecological time series study, statistical analysis with R 3.0.1, graphics with Excel 2013. Results: Between 2010 and 2013, 234 MD cases were reported in the MR with an increasing trend. There is a seasonal pattern with an increase of cases from August to October, and a decrease from March to April. There is no correlation with the levels of PM10 and PM2.5. There is a slight positive correlation with RH and a slight negative correlation with temperature. There is a moderate positive correlation with the levels of total environmental pollens. Discussion: Overcrowding and the winter viral infections could explain the increased incidence of MD and the slight correlation with RH and temperature. The moderate correlation with the pollens could be explained by an effect of irritation of the upper airway. Conclusions: More epidemiological studies whose designs allow a greater causal inference are required.

Introducción: La enfermedad meningocóccica (EM) constituye un problema de salud pública mundial debido a su alta morbi-mortalidad. La mayor cantidad de casos ocurre en África subsahariana, donde existe un marcado patrón estacional en la estación seca. Objetivos: Describir la morbilidad de la EM en la Región Metropolitana (RM) de Chile y explorar si existe correlación entre el número de casos con PM 10, PM 2,5 humedad relativa (HR), temperatura y pólenes ambientales totales. Materiales y Métodos: Estudio ecológico tipo series de tiempo, análisis estadístico con R 3.0.1, gráficos con Excel 2013. Resultados: En el período 2010-2013 se notificaron 234 casos de EM en la RM, con una tendencia al alza. Se observa un patrón estacional con aumento de casos entre agosto y octubre y una disminución entre marzo y abril. No existe correlación con los niveles de PM 10 ni de PM 2,5. Se describe una correlación positiva leve con la HR y negativa leve con la temperatura. Existe correlación moderada positiva con los niveles de pólenes totales ambientales. Discusión: El hacinamiento y las infecciones virales de invierno podrían explicar el aumento de casos de EM y la correlación leve con la HR y la temperatura. La correlación moderada con los pólenes podría explicarse por un efecto de irritación de la vía aérea superior. Conclusiones: Se requieren más estudios epidemiológicos cuyos diseños permitan una mayor inferencia causal.

Vigilancia de laboratorio de enfermedad meningocóccica invasora en Chile, 2006-2012 / Laboratory surveillance for invasive meningococcal disease in Chile, 2006-2012

Background: Laboratory surveillance of Invasive Meningococcal Disease (IMD) is performed by the Institute of Public Health of Chile. It confirms identification, classifies in serogroups and analyzes the genetic profiles of Neisseria meningitidis isolates from laboratories throughout the country. Aim: To show the results of this surveillance from 2006 to 2012. Methods: A descriptive data analysis of the confirmed cases of IMD and serological characterization, susceptibility and genetic profiles of the isolates. The analysis was disaggregated by serogroup, age and region. Results: From 2006 to 2012, 486 isolates of N. meningitidis were confirmed. In 2011 a rise in IMD rates was observed due to an increase in W serogroup cases, mainly affecting children aged 5 years or less. Serogroup W became the most prevalent during 2012 (58.3%), replacing the historically prevalent serogroup B. Predominating strains belonged to ST-32 complex/ET-5 complex (40, 4% of strains) and ST-41/44 complex/ Lineage 3 (45, 9% of strains). Conclusions: Laboratory surveillance has allowed the early detection of increasing IMD caused by serogroup W, which is emergent in Chile. This information has reinforced the daily monitoring of new cases, in collaboration with all the clinical laboratories of the country.

Introducción: La vigilancia de laboratorio de enfermedad meningocócica invasora (EMI) que realiza el Instituto de Salud Pública de Chile, confirma, seroagrupa y estudia el perfil genético de las cepas de Neisseria meningitidis provenientes de los laboratorios del país. Objetivo: En este artículo se muestra los resultados de esta vigilancia entre los años 2006 a 2012. Materiales y Métodos: Se realizó un análisis descriptivo de los casos confirmados de EMI, caracterización serológica, el análisis de susceptibilidad antimicrobiana y el estudio de subtipo genético de la cepa. El análisis se desagregó por serogrupo, edad y región. Resultados: En el período 2006-2012 fue confirmado un total de 486 cepas de N. meningitidis. A partir del año 2011 se observó un alza en la tasa de EMI dado por el número de casos del serogrupo W, afectando principalmente a niños bajo 5 años de edad. El W se transformó en el serogrupo prevalente el año 2012 (58,3%), desplazando al serogrupo B, el cual históricamente había sido prevalente. Predominaron principalmente las cepas pertenecientes al complejo clonal ST-32 complex/ET-5 complex (40,4% de las muestras) y el ST-41/44 complex/Lineage 3 (45,9% de las muestras). Conclusiones: El sistema de vigilancia de laboratorio ha permitido la identificación del serogrupo W, emergente en Chile. Esta información nos ha obligado a estar en permanente alerta y monitoreo de casos diarios, mediante la participación activa de todos los laboratorios clínicos del país.

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

OBJECTIVES: To analyze the behavior of meningococcal disease in the Federal District, Brazil, from 2005 to 2011, and to assess the direct impact of the meningococcal serogroup C conjugate vaccine. METHODS: A descriptive study of cases of meningococcal disease among residents of the Federal District. We included in the study confirmed cases of meningococcal disease reported to the local surveillance. To reduce underreporting we compared data to the Brazilian Mortality Database and the Public Health Laboratory Database. We studied sociodemographic, clinical, and pathogen-related variables. For the assessment of the impact of meningococcal serogroup C conjugate vaccine, which was introduced in 2010 for children under two years of age, we compared the incidence of meningococcal disease before and after vaccine introduction in the recommended age groups for vaccination. RESULTS: We identified 309 cases of meningococcal disease, of which 52.1% were males. The average case fatality rate was 20.7%, the median age was three years and there was a predominance of serogroup C (70.2%) and C:23:P1.14-6 phenotype throughout the study period. In 2005-2009, 2010 and 2011, the incidence rates of meningococcal disease were 2.0, 1.8 and 0.8/100,000 inhabitants/year, while mortality rates were 0.4, 0.4 and 0.2/100,000 inhabitants/year, respectively. In the first and last periods, the incidence in poorer and more affluent areas were, respectively, 2.0 and 0.8, and 0.9 and 0.0/100,000 inhabitants/year. Comparing 2009 (the year prior to the introduction of meningococcal serogroup C conjugate vaccine) and 2011, there was 85% reduction in the incidence of serogroup C meningococcal disease in children under four years of age, from 9.0 to 1.3/100,000 (p < 0.01). CONCLUSIONS: The meningococcal serogroup C conjugate vaccine strategy implemented in Brazil proved highly effective and had a strong direct impact on the target population. However, case ...

Caracterización clínica de los casos de enfermedad meningocóccica por serogrupo W135 confirmados durante el año 2012 en Chile / Clinical characterization of cases with meningococcal disease by W135 group in Chile, 2012

Background: During 2012 in Chile, there were 60 cases of serogroup W135 meningococcal disease, which accounts for 57.7% of identified serogroup cases. Aim: To describe main clinical features of patients with serogroup W135 meningococcal disease confirmed in 2012. Material and Methods: Descriptive study of case series based on retrospective review of medical records. Results: Male patients represented 61.7% and 46.7% were children under 5 years. At first clinical attention, 3.4% of patients were suspected of meningococcal disease, while 83.3% had meningococcemia as final diagnosis. Also at first attention, the most common symptoms or clinical signs were fever ≥ 38.0° C (60.3%), cold symptoms (52.5%), and nausea or vomiting (46.7%). Meningeal signs had a low frequency (8.7%). Diarrhea was the second most common symptom found among deceased patients (55.6%) and statistically higher than survivors (26.8%; p = 0.034). Six cases reported with sequelae: limb amputation, hearing loss or neurological damage, and mortality was 31.7%. Discussion: In 2012, serogroup W135 meningococcal disease reported high mortality, atypical clinical presentation, low initial meningococcal disease diagnosis, and a high number of cases with poor clinical course.

Introducción: En el año 2012 en Chile, se presentaron 60 casos de enfermedad meningocóccica (EM) causadas por serogrupo W135, que representa 57,7% de los casos seroagrupables. Objetivo: Describir las características clínicas de los casos de EM por serogrupo W135 confirmados durante el año 2012. Material y Métodos: Estudio descriptivo, de series de casos basada en la revisión de las fichas clínicas. Resultados: El 61,7% de los casos fueron varones y 46,7% tenía menos de 5 años. En la primera consulta, 3,4% tuvo sospecha de EM, en tanto 83,3% tuvo diagnóstico final de meningococcemia. En la primera consulta, los síntomas y/o signos más frecuentes fueron fiebre ≥ 38,0°C (60,3%), cuadro catarral respiratorio (52,5%) y náuseas y/o vómitos (46,7%). Mientras que los signos de irritación meníngea se presentaron en 8,7%. En los fallecidos la diarrea fue el segundo síntoma más frecuente (55,6%), y estadísticamente superior respecto de los sobrevivientes (26,8%; p = 0,034). Seis casos presentaron secuelas: amputaciones de extremidades, hipoacusia o daño neurológico y la letalidad fue de 31,7%. Discusión: la EM por el serogrupo W135 en el año 2012, tuvo una elevada letalidad, presentación clínica inespecífica, sospecha diagnóstica inicial baja y un alto número de casos cursaron con una mala evolución.

Avaliação dos fatores de risco para óbito em pacientes com doença meningocócica, Salvador, Bahia / Assessment of risk factors for death in patients with meningococcal disease, Salvador, Bahia / Evaluación de los factores de riesgo de muerte en pacientes com enfermedad meningocócica, Salvador, Bahia

A doença meningocócica (DM) apresenta relevância pela elevada incidência e mortalidade que apresenta. O objetivo deste artigo foi avaliar os fatores de risco para óbito em pacientes com doença meningocócica numa população de Salvador, Bahia. Trata-se de estudo de coorte histórica envolvendo 98 pacientes internados num hospital de referência no estado da Bahia de junho/2008 a maio/2009. Os dados clínicos, demográficos, epidemiológicos e laboratoriais foram obtidos por pesquisa nos prontuários e nas fichas do Núcleo de Vigilância Epidemiológica. Os resultados indicam a idade média de 15,6 (± 13,9) anos, 50 (51por cento) eram do sexo masculino e 68 (69,4por cento) procediam da capital. Evoluíram paraalta 85 (86,7por cento) pacientes e 13 (13,3por cento) para óbito. O tempo médio da doença foi de 48,2 horas. Meningite Meningocócica ocorreu em 54 (55,1por cento) casos, Meningite Meningocócica com Meningococcemia, em 28 (28,6por cento) e Meningococcemia, em 16 (16,3por cento). O sorogrupo C (57,74por cento) foi o mais prevalente. Concluiu-se que o tempo de doença foi menor nos pacientes que evoluíram para óbito e que a presença de irritação meníngea foi maior nos pacientes que evoluíram para alta. A presença de lesão de pele elevou o risco de evolução para óbito. Quanto maiores as alterações observadas no líquor e hemograma, maior a chance deevolução para alta hospitalar, sendo também estas alterações fatores de proteção de evolução para óbito.

Meningococcal disease (MD) has relevance for its high incidence and mortality rates. The purpose of this article was to evaluate risk factors for death in patients with meningococcal disease in a selected population of Salvador, Bahia. This is historical cohort study conducted with 98 patients hospitalized in a center of excellence hospital in the state of Bahia from June/2008 to May/2009. The clinical, demographic, epidemiological and laboratory data of the research were obtained from medical records and from the records of the Epidemiological Surveillance Center. The results indicate an average age of 15.6 (± 13.9) years, 50 (51percent) were male and 68 (69.4percent lived in the capital. The percentage of 86.7percent (85) patients were discharged from the hospital and 13 (13.3percent) died. The average length of time of the disease was 48.2 hours. Meningococcal meningitis occurred in 54 (55.1percent) cases, with Meningococcal Meningitis Meningococcemia, 28 (28.6percent) and Meningococcemia, 16 (16.3percent). The serogroup C (57,74percent) was the most prevalent. It was concluded that the disease duration was shorter in patients who died; the presence of meningeal irritation was higher in patients who were discharged.The presence of skin lesions increased the risk of progression to death. As to laboratory, CSF and hemogram, demonstrated that the greater the change observed the greater the chance of progression to discharge, these changes are also protective factors of progression to death.

La enfermedad meningocócica (MD) presenta relevancia por su elevadaincidencia y mortalidad. El objetivo de este artículo fue evaluar los factores de riesgo de muerte en pacientes con enfermedad meningocócica en la población de Salvador, Bahía. Estudio de enfoque histórico, realizado con 98 pacientes internos, de junio de 2008 a mayode 2009, en un hospital de referencia en el estado de Bahía. Los datos clínicos, demográficos, epidemiológicos y de laboratorio se obtuvieron a través de los históricos médicos y en los registros del Núcleo de Vigilancia Epidemiológica. Los resultados indican una edad media de 15,6 (±13,9) años, 50 (51por ciento) eran hombres y 68 (69,4por ciento) procedían de la capital. Un total de 85 (86,7por ciento) evolucionaron para alta y 13 pacientes (13,3por ciento) fallecieron. La duración media de la enfermedad fue de 48,2 horas. En 54 (55,1por ciento) de los casos se produjo meningitis meningocócica, en 28 (28,6por ciento) meningitis meningocócica con meningococcemia, y en 16(16,3por ciento) meningococcemia. El serogrupo C (57/74por ciento) fue el más frecuente. Se concluye que el tiempo de enfermedad fue menor en los pacientes que fueron a óbito y que la presencia de irritación meníngea fue mayor en los pacientes que evolucionaron para alta. La presencia delesiones en la piel aumenta el riesgo de óbito. Mientras mayor sean las alteraciones observadas en el LCR y en el hemograma, mayor será la probabilidad de evolucionar para alta hospitalaria representando, también, factores de protección con relación a la muerte.

Aspectos epidemiológicos da doença meningocócica no Distrito Federal, 2000 a 2011 / Epidemiological aspects of meningococcal disease in the Distrito Federal from 2000 to 2011

Objetivos: Analisar o comportamento da doença meningocócica (DM) no Distrito Federal (DF), no período de 2000 a 2011, investigar fatores associados à gravidade da doença e avaliar o impacto da introdução, em 2010, da vacina conjugada contra o meningococo C. Métodos: Trata-se de um estudo com um componente descritivo e outro analítico, abrangendo os residentes no DF que apresentaram DM. Foram incluídos os casos confirmados de DM registrados nos sistemas de informação de notificação e/ou de mortalidade e/ou do laboratório. Para a investigação de fatores associados ao óbito por DM, a variável dependente foi evolução e as variáveis independentes foram sexo, idade, forma clínica e sorogrupo da Neisseria meningitidis. Na avaliação do impacto da introdução da vacina conjugada contra o meningococo C, foram comparadas as taxas de incidência do período pré e pósvacina, por grupo etário. Resultados: Foram analisados 490 casos confirmados de DM no período. A cepa que predominou antes de 2005 foi a B:4,7:P1.19,15 com 67,8 por cento (61/90) e, a partir desse ano, predominaram as cepas C:23:P1.14-6 com 40,9 por cento (61/149) e C:2a:P1.5,2 com 12,8 por cento (19/149). As taxas médias anuais de incidência e de mortalidade por DM, no período, foram, respectivamente, 1,7 e 0,4/100.000 habitantes/ano e a letalidade média foi 21 por cento . A taxa de incidência de DM foi maior nas crianças menores de um ano, variando de 13,1 em 2011 a 38,7/100.000 habitantes/ano em 2000. A letalidade foi maior no grupo de 40 anos e mais, 40 por cento , e entre as crianças com dois anos, 32 por cento . A região administrativa (RA) do Paranoá foi a que apresentou as mais elevadas taxas médias anuais de incidência, 3,3/100.000 habitantes, e de mortalidade, 0,6/100.000 habitantes. Os menores de dois anos e os com idade maior ou igual a 30 anos tiveram risco significativamente maior para óbito, assim como as formas clínicas meningococcemia e meningite com meningococcemia. Houve uma redução estatisticamente significativa (p = 0,02) da incidência de DM em menores de dois anos do ano de 2009, 21,3/100.000 habitantes/ano, para o ano de 2011, 6,6/100.000 habitantes/ano. Conclusão: Esse estudo possibilitou verificar os grupos etários mais atingidos por DM, os fenótipos circulantes, as RA com as maiores taxas de incidência e de mortalidade e fazer uma avaliação preliminar do impacto da vacina conjugada contra o sorogrupo C, após o primeiro ano de sua introdução no calendário infantil de imunização.